SLEEPBIOTICS Trademark

Trademark Overview


On Tuesday, June 29, 2021, a trademark application was filed for SLEEPBIOTICS with the United States Patent and Trademark Office. The USPTO has given the SLEEPBIOTICS trademark a serial number of 90801832. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Monday, July 15, 2024. This trademark is owned by Biohm Health LLC. The SLEEPBIOTICS trademark is filed in the Pharmaceutical Products category with the following description:

Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liqu...
sleepbiotics

General Information


Serial Number90801832
Word MarkSLEEPBIOTICS
Filing DateTuesday, June 29, 2021
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Goods and ServicesProbiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; dietary supplements for medical use, namely metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal extracts sold as a component ingredient of nutritional supplements and vitamins and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome
Pseudo MarkSLEEP BIOTICS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOHM HEALTH INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCLEVELAND, OH 44113

Party NameBiohm Health LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCleveland, OH 44115

Party NameBiohm Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCleveland, OH 44115

Trademark Events


Event DateEvent Description
Saturday, September 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 10, 2022ASSIGNED TO EXAMINER
Wednesday, January 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 12, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022NEW NOA TO ISSUE
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 19, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 30, 2023SOU EXTENSION 1 FILED
Tuesday, May 30, 2023SOU EXTENSION 1 GRANTED
Thursday, June 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 28, 2023SOU EXTENSION 2 FILED
Tuesday, November 28, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, May 30, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, July 15, 2024PETITION GRANTED - EXTENSION REQUEST FILED
Monday, July 15, 2024NOTICE OF REVIVAL - E-MAILED
Monday, July 15, 2024ASSIGNED TO PETITION STAFF